HOME >> MEDICINE >> NEWS
Aspirin within two days of ischemic stroke reduces deaths

DALLAS, July 9 Giving patients aspirin within 48 hours of the onset of an acute ischemic stroke can reduce death and severity of stroke, according to a joint scientific statement from the American Stroke Association and the American Academy of Neurology.

An ischemic stroke is caused by a blood clot and is the most common type of stroke.

The statement, published in the July issues of Stroke: Journal of the American Heart Association, and Neurology, the scientific journal of the American Academy of Neurology, aims to define the roles of drugs such as aspirin which is in a class of drugs called antiplatelet agents that prevent blood clot formation and drugs such as heparin, a type of anticoagulant that slows blood clotting.

The authors conducted a systematic review of the literature, looking primarily for well-designed, large prospective studies in which patients were randomly selected and blinded (they didn't know what type of therapy they were receiving).

They found evidence from the published trials that giving 160 325 mg of aspirin within 48 hours of stroke onset offers a "small but statistically significant" decrease in death rates and disability from stroke. Recommendations on the use of other types of antiplatelet agents, such as clopidogrel and ticlopidine within the first 48 hours of onset could not be made due to insufficient data.

Conversely, anticoagulants have not been shown to reduce death or disability when used within 48 hours.

"There is some evidence that a fixed dose of heparin given subcutaneously might be helpful for preventing recurrent stroke, but the benefit is balanced against the complication of increased hemorrhage. With the net effect, there is no benefit to that treatment. Therefore, we are not recommending that one use a fixed dose of heparin given subcutaneously to prevent stroke recurrence," says neurologist Bruce Coull, M.D., chair of the Joint Stroke Guideline Development Commi
'"/>

Contact: Bridgette Mc Neill
bridgette.mcneill@heart.org
214-706-1135
American Heart Association
8-Jul-2002


Page: 1 2

Related medicine news :

1. Aspirins potential ability to prevent colon polyps may not apply equally to all
2. Aspirin underused to reduce heart disease risk in diabetic women and young adults
3. Long Island Breast Cancer Study data: Aspirin helps protect some women against breast cancer
4. Aspirin use associated with reduced risk of breast cancer
5. Aspirin use may be associated with increased risk of pancreatic cancer
6. Aspirin is most cost effective way to prevent heart disease
7. Aspirin withdrawal may pose risk to coronary patients
8. Aspirin does not reduce effectiveness of ACE inhibitors
9. Aspirin may help prevent pancreatic cancer
10. Aspirins target, the COX-2 enzyme, linked to cancer of the uterus
11. Aspirin steps up as anti-inflammatory for arteries

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Aspirin within two days ischemic stroke reduces deaths

(Date:3/5/2015)... 05, 2015 Central Nebraska Imaging (CNI) ... including the brand’s new logo and optimized website. ... practice’s modern approach to expert diagnostic imaging, centered on ... be built to be a resource for Nebraska patients ... automated forms, communication and referral functionality, video content and ...
(Date:3/5/2015)... Santa Rosa, CA (PRWEB) March 05, 2015 ... Like a SuperPro! The series aims to teach viewers ... indoor garden with hydroponics. Grow Like a SuperPro takes you ... in between. From how to clone, to how to prune ... of growing. They are offering the whole series for download ...
(Date:3/5/2015)... March 05, 2015 Califia Farms ... announced at Natural Products Expo West that its popular ... 100 percent soy and dairy free. Califia Farms Vegan ... bottle and are packed with six grams of an ... includes fiber, B vitamins and magnesium. , Protein is ...
(Date:3/5/2015)... Diego, CA (PRWEB) March 05, 2015 ... the purest and most essential ingredients, the robust flavor ... of allergic reactions. PASCHA Chocolate is free from ... and sesame. Experience PASCHA's offering March 6th- 8th at ... Chocolate Spread. PASCHA Chocolate has broken new ground ...
(Date:3/5/2015)... 05, 2015 Today, Earth Source ... on 100% pollution-free electricity through a partnership with ... As an Arcadia Power Clean Energy Partner, ESO ... Power Partnership requirements, joining national brands such as ... clean energy. Earth Source Organics joins a growing ...
Breaking Medicine News(10 mins):Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 3Health News:PASCHA Allergen Free Organic Chocolate to Appear at Natural Products Expo West March 6-8, 2015 2Health News:Earth Source Organics to Run on Clean Energy from Arcadia Power 2
(Date:3/5/2015)... and HAMPTON, N.J. , March ... MNK ), a leading global specialty biopharmaceutical ... announced today that they have entered into a definitive ... Ikaria, Inc. from a Madison Dearborn -led investor ... Subject to customary closing conditions, the ...
(Date:3/5/2015)... March 5, 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: ... of regenerative medicine, announced today that Atlanta ... rehabilitation hospitals for spinal cord injury and brain injury, ... of AST-OPC1 (oligodendrocyte progenitor cells) in newly injured patients ... (SCI). The Phase 1/2a trial follows ...
(Date:3/5/2015)... March 5, 2015  MGC Diagnostics Corporation (NASDAQ: ... company, today reported financial results for the first ... 2015 first quarter domestic equipment, supplies and accessories ... $3.7 million in the 2014 first quarter.  During ... or $338,000 in revenue, compared to 14 accounts, ...
Breaking Medicine Technology:Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 2MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 3MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 4MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 5MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 6MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 7MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 8MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 9MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 10MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 11MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 12
Cached News: